NVIDIA Investment Quality Review (NVDA)

Data timestamp: 2026-07-17 22:06 UTC
Quality score: 83/100 Valuation position: price/base fair value 1.11 Final signal: WATCHLIST

Core View

The report keeps the stock on the watchlist because business quality is not matched by sufficient valuation safety. The current price is 202.81USD; conservative and base fair values are 158.19/182.53USD. The source report’s conclusion is preserved: this is not a buy upgrade unless the margin of safety improves and the evidence base remains intact.

Quality is scored at 83/100. The positive evidence is the five-year financial baseline, latest free cash flow, and balance-sheet bridge. The main limits are valuation, incomplete segment-margin disclosure, and the need to keep validating shareholder returns, incentives, related-party exposure, accounting quality, and financial-asset composition from official filings.

Business Breakdown

The source report uses the consolidated business line as the operating base. Revenue moved from USD 26.9bn to USD 215.9bn, with a five-year change of 68.3% CAGR. Latest segment margin or segment profit is not disclosed, so no undisclosed segment margin is inferred.

The value driver is the multi-year revenue trend and the latest-year FCF. The business breakdown feeds the quality score and FCF multiple range; it is not treated as a separate valuation shortcut. Management outlook is used only when disclosed through annual reports, exchange filings, or company IR materials.

Business Quality

The scorecard totals 83/100: business model 8/10, moat 15/20, cash flow 18/20, capital return 12/15, balance sheet 9/10, growth quality 8/10, and management/accounting 13/15.

Cash-flow evidence: FCF/ 0.85OCF/ 0.98. Capital-return evidence: 5ROE 75.0%ROIC. Balance-sheet evidence: USD 10.6bnUSD 15.8bn. Growth evidence: CAGR 68.3%FCF CAGR 85.7%. The management and accounting score remains deliberately conservative until dividends, buybacks, incentive dilution, related-party items, abnormal gains, and audit evidence are checked item by item.

Financial Audit

The valuation uses 2026, 2025, 2024, 2023, 2022; quote currency is USD, valuation currency is USD, and the risk-free-rate input is the USD 10-year Treasury reference rate. ROIC is used only when the structured invested-capital baseline supports it.

Latest-year financials (2026): revenue USD 215.9bn, net profit USD 120.1bn, OCF USD 102.7bn, capex USD 6.0bn, FCF USD 96.7bn, ROE 101.5%, ROIC not disclosed, FCF/Revenue 44.8%, and FCF/Net Income 0.81.

Latest balance sheet (2026): cash and equivalents USD 10.6bn, current financial assets USD 52.0bn, non-current financial assets USD 22.3bn, total debt USD 15.8bn, and net cash/debt -USD 5.2bn. If goodwill, receivables, inventory, financial-asset marks, or off-balance-sheet obligations change materially, the fair-value bridge must be rechecked before the signal can improve.

Valuation

The model uses normalized FCF as the main anchor, then adjusts for cash, financial assets, debt, dilution, and other senior claims in common-equity order. The current price/base FV ratio is 1.11, so the base case does not satisfy the 2x discipline.

Conservative case: USD 158.19 per share, price/FV 1.28, weight 30%.
Base case: USD 182.53 per share, price/FV 1.11, weight 50%.
Optimistic case: USD 239.32 per share, price/FV 0.85, weight 20%.

The balance-sheet bridge contributes cash USD 9.5bn, current financial assets USD 28.6bn, non-current financial assets USD 6.7bn, debt and senior claims -USD 15.8bn, and total adjustment USD 29.0bn. Dividends and buybacks are cross-checks for capital allocation and are not double-counted in FV.

Buy And Tracking Discipline

Current action: keep the stock on the stated signal and do not upgrade without a wider margin of safety. A BUY case requires price/base FV below 0.70, quality score of at least 75, and stronger evidence that the market is mispricing a still-healthy business. A 2x case requires price/base FV at or below 0.50 or new primary evidence that materially raises base fair value.

Tracking priorities are revenue trend, FCF/Net Income, OCF/Net Income, ROIC where reliable, net cash/debt, dividends, buybacks, incentive dilution, related-party disclosures, segment economics, and governance/accounting evidence.

Risks To Recheck

The key risks are repeatable FCF, balance-sheet bridge reliability, accounting and governance evidence, and shareholder-return quality. FCF that fails to repeat would lower the base multiple and the BUY threshold. Larger debt, weaker liquidity, or financial-asset impairment would reduce conservative FV. Harmful dilution, weak buyback discipline, related-party issues, or abnormal gains would reduce the management/accounting score.

Revaluation triggers are the same as in the Chinese report: two reporting periods with FCF/Net Income below 0.60; a visible increase in net debt or a material financial-asset impairment; or dividends, buybacks, incentives, or dilution that reduce ordinary-shareholder value. Any of these would require a lower quality score, lower fair value, or a weaker final signal.

Sources

The evidence set is unchanged from the Chinese report and covers market price, market value, share count, five-year financial baseline, official annual/interim filings, dividends, buybacks, governance, related-party transactions, incentives, risk disclosures, the risk-free-rate input, and currency alignment. Source URLs: https://www.nasdaq.com/; https://www.sec.gov/edgar/browse/?CIK=1045810; https://fred.stlouisfed.org/series/DGS10; https://www.nasdaq.com/.

Research note: This memo is for personal research only and is not personalized investment advice.